It is hypothesized that severity of established CTRCD in this subgroup might be too advanced for significant LVEF improvements, and statins hold promise in the prevention of anthracycline- and/or anti-HER2-mediated CTRCD, whereas no beneficial effect was observed in patients with combination regimens.
Y. Appels, R. Parvan, C. G. Mohan et al.· European Heart Journal, Supp...· 0 citations
The manifold of CVD and CV health indicators increase the risk of new-onset cancer and cancer-related mortality, and the need for awareness of future cancer in patients with CVD is emphasized.
L. Yousif, P. Ameri, M. Vinci et al.· European Heart Journal, Supp...· 0 citations
Findings indicate that the variant rs72705424 is associated with higher circulating PD-L1 levels and that elevated PD-L1 increases the risk of incident CVD, and highlight how genetic variation can affect circulating factors and the subsequent CVD risks.
A. Sijtema, L. Yousif, M. Asik et al.· European Heart Journal, Supp...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.